Trial intelligence / Profile preview

Hyzetimibe + Atorvastatin in Hypercholesterolemia with CHD

NCT03433196Phase 3Completed

Sponsor
Zhejiang Hisun Pharmaceutical Co., Ltd.
Start
Jun 2016
Primary completion
Jun 2018
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of hybutimibe in hypercholesterolemia, sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Jun 2016; status: completed.

02

Drugs

hybutimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT03433196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03433196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call